{
    "nct_id": "NCT03744026",
    "official_title": "A Study to Evaluate the Safety and the Efficacy of Transient Opening of the Blood-brain Barrier (BBB) by Low Intensity Pulsed Ultrasound With the SonoCloud-9 Implantable Device in Recurrent Glioblastoma Patients Eligible for Surgery and for Carboplatin Chemotherapy",
    "inclusion_criteria": "1. Age ≥ 18 years, able and willing to give signed and informed consent.\n2. Patient with histologically proven recurrent de novo GBM:\n\n   1. After at least a first-line standard of care (maximal safe resection, if feasible, radiation with temozolomide [TMZ], then TMZ);\n   2. Any recurrence;\n   3. Bevacizumab-naïve.*\n3. Patient eligible for carboplatin-based chemotherapy.\n4. Patient eligible for a surgical resection.\n5. Maximal tumor diameter at inclusion (pre surgery) ≤ 70 mm in T1wMRI.\n6. Patients should be stable, without evidence of a midline shift, significant peritumoral edema, or rapid progression of clinical symptoms.\n7. Karnofsky performance status ≥ 70.\n8. Patient receiving prednisone dose ≤ 40 mg (dexamethasone ≤ 6 mg) for at least 7 days.\n\nKey\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Multifocal tumor (unless all localized in a 70 mm diameter area).\n2. Patients at risk of surgery site infection (2 or more previous craniotomies, neurosurgery within the last 3 months, poor skin condition, and/or previously infected surgical field).\n3. Posterior fossa tumor.\n4. Uncontrolled epilepsy.\n5. Patients with evidence of uncontrolled intracranial pressure.\n6. Patients with known intracranial aneurism or having presented intra-tumor spontaneous hemorrhage.\n7. Patients with coils, clips, shunts, intravascular stents, and/or unremovable wafer, non resorbable dura substitute, or reservoirs.\n8. Patients with medical need to continue antiplatelet therapy.\n9. Patients with known or suspected active or chronic infections.",
    "miscellaneous_criteria": "Key"
}